Obstetrics and gynecology
-
Obstetrics and gynecology · Nov 2018
Randomized Controlled Trial Multicenter StudyElagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
To evaluate elagolix, an oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy, in premenopausal women with heavy menstrual bleeding (greater than 80 mL per month) associated with uterine leiomyomas. ⋯ ClinicalTrials.gov, NCT01817530; EU Clinical Trial Register, 2013-000082-37.
-
Obstetrics and gynecology · Nov 2018
Randomized Controlled TrialTorsemide for Prevention of Persistent Postpartum Hypertension in Women With Preeclampsia: A Randomized Controlled Trial.
To evaluate whether torsemide reduces the rate of persistent postpartum hypertension in women with preeclampsia. ⋯ ClinicalTrials.gov, NCT02813551.
-
Obstetrics and gynecology · Nov 2018
Practice GuidelineACOG Committee Opinion No. 757: Screening for Perinatal Depression.
Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting one in seven women. It is important to identify pregnant and postpartum women with depression because untreated perinatal depression and other mood disorders can have devastating effects. Several screening instruments have been validated for use during pregnancy and the postpartum period. ⋯ If a patient is screened for depression and anxiety during pregnancy, additional screening should then occur during the comprehensive postpartum visit. There is evidence that screening alone can have clinical benefits, although initiation of treatment or referral to mental health care providers offers maximum benefit. Therefore, clinical staff in obstetrics and gynecology practices should be prepared to initiate medical therapy, refer patients to appropriate behavioral health resources when indicated, or both.
-
Obstetrics and gynecology · Nov 2018
ACOG Committee Opinion No. 757 Summary: Screening for Perinatal Depression.
Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting one in seven women. It is important to identify pregnant and postpartum women with depression because untreated perinatal depression and other mood disorders can have devastating effects. Several screening instruments have been validated for use during pregnancy and the postpartum period. ⋯ If a patient is screened for depression and anxiety during pregnancy, additional screening should then occur during the comprehensive postpartum visit. There is evidence that screening alone can have clinical benefits, although initiation of treatment or referral to mental health care providers offers maximum benefit. Therefore, clinical staff in obstetrics and gynecology practices should be prepared to initiate medical therapy, refer patients to appropriate behavioral health resources when indicated, or both.
-
Obstetrics and gynecology · Nov 2018
Racial and Ethnic Disparities in the Incidence of Severe Maternal Morbidity in the United States, 2012-2015.
To describe racial and ethnic disparities in the incidence of severe maternal morbidity during delivery hospitalizations in the United States. ⋯ Programs for reducing racial and ethnic disparities in severe maternal morbidity may have the greatest effect focusing on women at highest risk for blood transfusion and maternity care management for women with comorbid chronic conditions, particularly multiple chronic conditions.